AIMS: To investigate the presence and prognostic relevance of KIT expression in paediatric renal tumours, and to determine whether receptor overexpression is associated with gene amplification and/or mutation. METHODS: Immunohistochemistry without antigen retrieval for CD117 was carried out on tissue microarrays consisting of 274 Wilms' tumours, 13 clear cell sarcomas of the kidney (CCSK), 10 mesoblastic nephromas (MN), and 7 rhabdoid tumours of the kidney (RTK). In addition, gene copy number was investigated by chromogenic in situ hybridisation (CISH), and overexpressing tumours were sequenced for KIT mutations in exons 9, 11, 13 and 17. RESULTS: Only 8/200 (4.0%) Wilms' tumours exhibited any degree of moderate-strong KIT staining in any of their assessable cell types. This small group of KIT-positive tumours had a shorter time to relapse (p = 0.0044, log-rank test). There were no positive MNs or RTKs; however 3/11 (27.3%) CCSKs were strongly positive, with an additional two cases weakly reactive. No cases exhibited gene amplification or mutation. CONCLUSIONS: KIT overexpression in rare in Wilms' tumours, although does appear to confer a worse prognosis, in particular for patients primarily treated with preoperative chemotherapy. CCSKs are associated with an increased expression of KIT, however, in the absence of gene amplification and/or activating mutation. The potential of anti-KIT therapeutic strategies in the treatment of paediatric renal tumours appears to be limited.
AIMS: To investigate the presence and prognostic relevance of KIT expression in paediatric renal tumours, and to determine whether receptor overexpression is associated with gene amplification and/or mutation. METHODS: Immunohistochemistry without antigen retrieval for CD117 was carried out on tissue microarrays consisting of 274 Wilms' tumours, 13 clear cell sarcomas of the kidney (CCSK), 10 mesoblastic nephromas (MN), and 7 rhabdoid tumours of the kidney (RTK). In addition, gene copy number was investigated by chromogenic in situ hybridisation (CISH), and overexpressing tumours were sequenced for KIT mutations in exons 9, 11, 13 and 17. RESULTS: Only 8/200 (4.0%) Wilms' tumours exhibited any degree of moderate-strong KIT staining in any of their assessable cell types. This small group of KIT-positive tumours had a shorter time to relapse (p = 0.0044, log-rank test). There were no positive MNs or RTKs; however 3/11 (27.3%) CCSKs were strongly positive, with an additional two cases weakly reactive. No cases exhibited gene amplification or mutation. CONCLUSIONS: KIT overexpression in rare in Wilms' tumours, although does appear to confer a worse prognosis, in particular for patients primarily treated with preoperative chemotherapy. CCSKs are associated with an increased expression of KIT, however, in the absence of gene amplification and/or activating mutation. The potential of anti-KIT therapeutic strategies in the treatment of paediatric renal tumours appears to be limited.
Authors: Colleen Cutcliffe; Donna Kersey; Chiang-Ching Huang; Yong Zeng; David Walterhouse; Elizabeth J Perlman Journal: Clin Cancer Res Date: 2005-11-15 Impact factor: 12.531
Authors: R Natrajan; R D Williams; S N Hing; A Mackay; J S Reis-Filho; K Fenwick; M Iravani; H Valgeirsson; A Grigoriadis; C F Langford; O Dovey; S G Gregory; B L Weber; A Ashworth; P E Grundy; K Pritchard-Jones; C Jones Journal: J Pathol Date: 2006-09 Impact factor: 7.996
Authors: Rui M Reis; Albino Martins; Susana A Ribeiro; Diana Basto; Adhemar Longatto-Filho; Fernando C Schmitt; José M Lopes Journal: Cell Oncol Date: 2005 Impact factor: 6.730
Authors: Rachael Natrajan; Jorge S Reis-Filho; Suzanne E Little; Boo Messahel; Marie-Anne Brundler; Jeffrey S Dome; Paul E Grundy; Gordan M Vujanic; Kathy Pritchard-Jones; Chris Jones Journal: Cancer Res Date: 2006-12-01 Impact factor: 12.701
Authors: Raisa Vuononvirta; Neil J Sebire; Boo Messahel; Nina Perusinghe; Jorge S Reis-Filho; Kathy Pritchard-Jones; Gordan M Vujanic; Chris Jones Journal: Clin Cancer Res Date: 2009-03-24 Impact factor: 12.531
Authors: Zeynep Canan Ozdemir; Burcu Ayvaci; Yeter Duzenli Kar; Mehmet Oguzman; Mehmet Surhan Arda; Mustafa Fuat Acikalin; Ozcan Bor Journal: North Clin Istanb Date: 2018-01-18